JP2011105609A5 - - Google Patents

Download PDF

Info

Publication number
JP2011105609A5
JP2011105609A5 JP2009259479A JP2009259479A JP2011105609A5 JP 2011105609 A5 JP2011105609 A5 JP 2011105609A5 JP 2009259479 A JP2009259479 A JP 2009259479A JP 2009259479 A JP2009259479 A JP 2009259479A JP 2011105609 A5 JP2011105609 A5 JP 2011105609A5
Authority
JP
Japan
Prior art keywords
combination
subject
combination according
metformin
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009259479A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011105609A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2009259479A priority Critical patent/JP2011105609A/ja
Priority claimed from JP2009259479A external-priority patent/JP2011105609A/ja
Publication of JP2011105609A publication Critical patent/JP2011105609A/ja
Publication of JP2011105609A5 publication Critical patent/JP2011105609A5/ja
Pending legal-status Critical Current

Links

JP2009259479A 2009-11-13 2009-11-13 メトホルミンへの付加療法を含む２型糖尿病の治療方法 Pending JP2011105609A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009259479A JP2011105609A (ja) 2009-11-13 2009-11-13 メトホルミンへの付加療法を含む２型糖尿病の治療方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009259479A JP2011105609A (ja) 2009-11-13 2009-11-13 メトホルミンへの付加療法を含む２型糖尿病の治療方法

Publications (2)

Publication Number Publication Date
JP2011105609A JP2011105609A (ja) 2011-06-02
JP2011105609A5 true JP2011105609A5 (es) 2012-12-13

Family

ID=44229535

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009259479A Pending JP2011105609A (ja) 2009-11-13 2009-11-13 メトホルミンへの付加療法を含む２型糖尿病の治療方法

Country Status (1)

Country Link
JP (1) JP2011105609A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102495217B (zh) * 2011-12-06 2014-06-25 黄传峰 一种临床病例监测管理系统

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1076066A1 (en) * 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels

Similar Documents

Publication Publication Date Title
ES2553593T3 (es) Lixisenatida como complemento de la metformina en el tratamiento de la diabetes tipo 2
JP2013525444A5 (es)
HRP20121029T4 (hr) Liksisenatid kao pomoćna terapija uz inzulin glargin i metformin kod liječenja dijabetesa tip 2
JP2012520866A5 (es)
HRP20161620T1 (hr) Uporaba ave0010 za proizvodnju lijeka za liječenje dijabetes melitusa tip 2
JP2014511863A5 (es)
RU2014111821A (ru) Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
JP2010280671A5 (es)
PH12016500959B1 (en) Use of nutritional compositions having a low protein amount
AR086356A1 (es) Combinacion farmaceutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2
MX2012006734A (es) Tiazolidinadionas moderadoras de receptores activados por proliferador de peroxisoma (ppar) y combinaciones para el tratamiento de obesidad y otras enfermedades metabolicas.
JP2014514361A5 (es)
JP2017538705A5 (es)
JP2009528985A5 (es)
AR103415A1 (es) Tratamiento de pacientes pediátricos con diabetes mellitus de tipo 2
JP2018503644A5 (es)
JP2015516419A5 (es)
JP2018509419A5 (es)
RU2013137645A (ru) Аналоги цистамина, применяемые для лечения болезни паркинсона
EA201071138A1 (ru) Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона
JP2011105610A5 (es)
JP2011105609A5 (es)
JP2012525422A5 (es)
RU2014150946A (ru) Способ снижения веса
WO2012082765A3 (en) Methods for decreasing body weight and treating diabetes